Filing Flows › Petmed Express (PETS) › Q3 FY26
Petmed Express (PETS) Q3 FY26 earnings results (third quarter fiscal 2026)
10-Q filed Feb 5, 2026
Petmed Express (PETS) reported revenue of $40.7M for the third quarter fiscal 2026 (Q3 FY26), -22% from a year earlier and -8% from the quarter before. Operating margin was -25.7%, net loss $10.6M (26.0% of revenue).
Petmed Express, Q3 FY26: revenue $40.7M (-22% year over year), operating margin -25.7%, net loss $10.6M, operating cash flow −$9.2M. The chart follows the revenue to costs, profit and cash.
| Q3 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $40.7M | -8% | -22% |
| Operating profit | −$10.5M | — | — |
| Net earnings | −$10.6M | — | — |
| Operating cash flow | −$9.2M | — | — |
What changed
Revenue was $40.7M in Q3 FY26, down 22% year over year and down 8% from the previous quarter.
Gross margin was 23.3%, down 7.8 points from Q3 FY25. Operating costs exceeded revenue by $10.5M, an operating margin of -25.7%. Operating expenses grew 20% against a revenue fall of 22%. The fastest-growing cost line was Other operating costs (+33%). The quarter ended with a net loss of $10.6M, wider than the previous quarter's $8.5M loss.
Operating cash flow was −$9.2M. Non-cash charges added back $2.4M of depreciation and amortization and $300K of share-based compensation. Working capital and other items used $1.4M. Capital expenditures of −$21K exceeded it, leaving free cash flow of −$9.2M.
Questions
What was Petmed Express' revenue in the third quarter fiscal 2026?
Petmed Express (PETS) reported revenue of $40.7M for the third quarter fiscal 2026 (Q3 FY26), -22% from a year earlier and -8% from the quarter before.
Was Petmed Express profitable in the third quarter fiscal 2026?
Operating loss was $10.5M (-25.7% of revenue) and net loss $10.6M.
Source: Petmed Express 10-Q on SEC EDGAR.